187 related articles for article (PubMed ID: 7967990)
1. Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits.
Sanchez JL; Vasquez B; Begue RE; Meza R; Castellares G; Cabezas C; Watts DM; Svennerholm AM; Sadoff JC; Taylor DN
Lancet; 1994 Nov; 344(8932):1273-6. PubMed ID: 7967990
[TBL] [Abstract][Full Text] [Related]
2. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam.
Trach DD; Clemens JD; Ke NT; Thuy HT; Son ND; Canh DG; Hang PV; Rao MR
Lancet; 1997 Jan; 349(9047):231-5. PubMed ID: 9014909
[TBL] [Abstract][Full Text] [Related]
3. Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru.
Taylor DN; Cárdenas V; Sanchez JL; Bégué RE; Gilman R; Bautista C; Perez J; Puga R; Gaillour A; Meza R; Echeverria P; Sadoff J
J Infect Dis; 2000 May; 181(5):1667-73. PubMed ID: 10823767
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
[TBL] [Abstract][Full Text] [Related]
5. Immunological response to Vibrio cholerae O1 infection and an oral cholera vaccine among Peruvians.
Sanchez JL; Hayashi KE; Kruger HF; Meza R; English CK; Vidal W; Svennerholm AM; Taylor DN
Trans R Soc Trop Med Hyg; 1995; 89(5):542-5. PubMed ID: 8560536
[TBL] [Abstract][Full Text] [Related]
6. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.
Bhattacharya SK; Sur D; Ali M; Kanungo S; You YA; Manna B; Sah B; Niyogi SK; Park JK; Sarkar B; Puri MK; Kim DR; Deen JL; Holmgren J; Carbis R; Dhingra MS; Donner A; Nair GB; Lopez AL; Wierzba TF; Clemens JD
Lancet Infect Dis; 2013 Dec; 13(12):1050-6. PubMed ID: 24140390
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial.
Sur D; Lopez AL; Kanungo S; Paisley A; Manna B; Ali M; Niyogi SK; Park JK; Sarkar B; Puri MK; Kim DR; Deen JL; Holmgren J; Carbis R; Rao R; Nguyen TV; Donner A; Ganguly NK; Nair GB; Bhattacharya SK; Clemens JD
Lancet; 2009 Nov; 374(9702):1694-702. PubMed ID: 19819004
[TBL] [Abstract][Full Text] [Related]
8. Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.
Tacket CO; Cohen MB; Wasserman SS; Losonsky G; Livio S; Kotloff K; Edelman R; Kaper JB; Cryz SJ; Giannella RA; Schiff G; Levine MM
Infect Immun; 1999 Dec; 67(12):6341-5. PubMed ID: 10569747
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial.
Qadri F; Ali M; Lynch J; Chowdhury F; Khan AI; Wierzba TF; Excler JL; Saha A; Islam MT; Begum YA; Bhuiyan TR; Khanam F; Chowdhury MI; Khan IA; Kabir A; Riaz BK; Akter A; Khan A; Asaduzzaman M; Kim DR; Siddik AU; Saha NC; Cravioto A; Singh AP; Clemens JD
Lancet Infect Dis; 2018 Jun; 18(6):666-674. PubMed ID: 29550406
[TBL] [Abstract][Full Text] [Related]
10. Safety, immunogenicity, and lot stability of the whole cell/recombinant B subunit (WC/rCTB) cholera vaccine in Peruvian adults and children.
Taylor DN; Cárdenas V; Perez J; Puga R; Svennerholm AM
Am J Trop Med Hyg; 1999 Dec; 61(6):869-73. PubMed ID: 10674661
[TBL] [Abstract][Full Text] [Related]
11. Field trial of oral cholera vaccines in Bangladesh.
Clemens JD; Sack DA; Harris JR; Chakraborty J; Khan MR; Stanton BF; Kay BA; Khan MU; Yunus M; Atkinson W
Lancet; 1986 Jul; 2(8499):124-7. PubMed ID: 2873397
[TBL] [Abstract][Full Text] [Related]
12. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
13. An oral B subunit: whole cell vaccine against cholera.
Holmgren J; Svennerholm AM; Jertborn M; Clemens J; Sack DA; Salenstedt R; Wigzell H
Vaccine; 1992; 10(13):911-4. PubMed ID: 1471411
[TBL] [Abstract][Full Text] [Related]
14. The design and analysis of cholera vaccine trials: recent lessons from Bangladesh.
Clemens J; Sack D; Rao M; Chakraborty J; Kay B; Ahmed F; Khan MR; van Loon FP; Svennerholm AM; Holmgren J
Int J Epidemiol; 1993 Aug; 22(4):724-30. PubMed ID: 8225749
[TBL] [Abstract][Full Text] [Related]
15. Oral vaccines for cholera control.
Chaturvedi S; Chaturvedi S
Natl Med J India; 1997; 10(1):17-8. PubMed ID: 9069701
[TBL] [Abstract][Full Text] [Related]
16. Impaired immune response to natural infection as a correlate of vaccine failure in a field trial of killed oral cholera vaccines.
Clemens J; Rao M; Sack D; Ahmed F; Khan MR; Chakraborty J; Kay B; Huda S; Yunus M; van Loon F
Am J Epidemiol; 1995 Oct; 142(7):759-64. PubMed ID: 7572947
[TBL] [Abstract][Full Text] [Related]
17. Evidence that inactivated oral cholera vaccines both prevent and mitigate Vibrio cholerae O1 infections in a cholera-endemic area.
Clemens JD; Sack DA; Rao MR; Chakraborty J; Khan MR; Kay B; Ahmed F; Banik AK; van Loon FP; Yunus M
J Infect Dis; 1992 Nov; 166(5):1029-34. PubMed ID: 1402014
[TBL] [Abstract][Full Text] [Related]
18. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R
Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of mass oral cholera vaccination in Beira, Mozambique.
Lucas ME; Deen JL; von Seidlein L; Wang XY; Ampuero J; Puri M; Ali M; Ansaruzzaman M; Amos J; Macuamule A; Cavailler P; Guerin PJ; Mahoudeau C; Kahozi-Sangwa P; Chaignat CL; Barreto A; Songane FF; Clemens JD
N Engl J Med; 2005 Feb; 352(8):757-67. PubMed ID: 15728808
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age.
Saha A; Chowdhury MI; Khanam F; Bhuiyan MS; Chowdhury F; Khan AI; Khan IA; Clemens J; Ali M; Cravioto A; Qadri F
Vaccine; 2011 Oct; 29(46):8285-92. PubMed ID: 21907255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
